Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN953576 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Myosin VI (MYO6) (C-Term), (AA 1173-1203) antibody
- Antibody type
- Polyclonal
- Antigen
- conjugated synthetic peptide between 1173-1203 amino acids from the C-terminal region of Human MYO6. Genename: MYO6
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term,AA 1173-1203
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Switch between large hand-over-hand and small inchworm-like steps in myosin VI.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners.
The microRNA profile of prostate carcinoma obtained by deep sequencing.
Role of macrophage oxidative burst in the action of anthrax lethal toxin.
Nishikawa S, Arimoto I, Ikezaki K, Sugawa M, Ueno H, Komori T, Iwane AH, Yanagida T
Cell 2010 Sep 17;142(6):879-88
Cell 2010 Sep 17;142(6):879-88
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners.
Cho SJ, Chen X
The Journal of biological chemistry 2010 Aug 27;285(35):27159-66
The Journal of biological chemistry 2010 Aug 27;285(35):27159-66
The microRNA profile of prostate carcinoma obtained by deep sequencing.
Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F
Molecular cancer research : MCR 2010 Apr;8(4):529-38
Molecular cancer research : MCR 2010 Apr;8(4):529-38
Role of macrophage oxidative burst in the action of anthrax lethal toxin.
Hanna PC, Kruskal BA, Ezekowitz RA, Bloom BR, Collier RJ
Molecular medicine (Cambridge, Mass.) 1994 Nov;1(1):7-18
Molecular medicine (Cambridge, Mass.) 1994 Nov;1(1):7-18
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of MYO6 Antibody (C-term) Cat.-No AP52797PU-N in MCF-7 cell line lysates (35ug/lane). This demonstrates the MYO6 antibody detected the MYO6 protein (arrow).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Confocal immunofluorescent analysis of MYO6 Antibody (C-term) Cat.-No AP52797PU-N with MCF-7 cell followed by Alexa Fluor®488 conjugated Goat anti-Rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Formalin fixed and paraffin embedded human brain tissue stained with MYO6 Antibody (C-term) Cat.-No AP52797PU-N followed by peroxidase conjugation of the secondary antibody and DAB staining.
